Build your career on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
Join a dynamic international team and help accelerate drug development for patients with epidermolysis bullosa!
As part of the COSEB project, you'll be at the forefront of standardizing outcome measurement in EB research. Work with passionate clinicians, researchers and EB patient advocates across continents, and gain invaluable experience in clinimetric methods and patient-centered research.
What will you do?
Epidermolysis bullosa (EB) is a rare genetic skin blistering disorder that significantly impacts patients' quality of life. Despite ongoing research and drug development efforts, no cure or effective treatment currently exists. The lack of standardized and patient-centered outcome measurement hinders progress in evaluating treatments and improving patient care. This PhD project aims to address that.
Within the international project “Core Outcome Sets for Epidermolysis Bullosa (COSEB)”, you will focus on the development and implementation of core outcome sets for EB. The project brings together an international consortium of clinicians, researchers, patients, and other stakeholders to improve outcome measurement, expedite drug development, and ultimately enhance outcomes for people living with EB.
Your PhD trajectory will focus on:
The project will involve clinimetric methods, qualitative research approaches (interviews, thematic analysis), Delphi methodology, and consensus techniques in close collaboration with patients and other stakeholders.
You will work at the Department of Dermatology of the UMCG, which hosts an internationally recognized EB expertise center.
You can expect:
We are looking for a candidate who:
Het Universitair Medisch Centrum Groningen (UMCG) is één van de grootste ziekenhuizen in Nederland en is de grootste werkgever van Noord-Nederland. De ruim 12.000 medewerkers werken samen aan zorg, onderzoek, opleiding en onderwijs met als gemeenschappelijke doelstelling: bouwen aan de toekomst van gezondheid.
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over ‘bedrijfsnaam’ op hun website: ‘’Carrierewebsite’’
View what's on offer:
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.